三型自身免疫性多腺体综合征（APS III）缓解的诱导：一种具有新前景的老药物。
Induction of remission in autoimmune polyglandular syndrome type three (APS III): An old drug with new perspectives.
作者信息
Allam Magdy Mohamed, Elzawawy Hanaa Tarek Hussein
机构信息
Internal Medicine Department Alexandria University Student Hospital (AUSH) Alexandria Egypt.
Internal Medicine Department, Faculty of Medicine Alexandria University Alexandria Egypt.
出版信息
Clin Case Rep. 2018 Oct 2;6(11):2178-2184. doi: 10.1002/ccr3.1827. eCollection 2018 Nov.
The autoimmune polyglandular syndrome is a sequential chain of autoimmune events. Whenever diagnosed, the clinician's target should be induction of remission and if possible hindering its progression especially if associated with refractory vitiligo, resistant Grave's, or unexplained hyperglycemia in T1DM. Azathioprine could be used for induction of remission in autoimmune polyglandular syndrome type three especially with vitiligo and autoimmune thyroiditis.
自身免疫性多腺体综合征是一系列自身免疫事件。一旦确诊，临床医生的目标应是诱导缓解，若可能应阻止其进展，尤其是在与难治性白癜风、耐药性格雷夫斯病或1型糖尿病中无法解释的高血糖相关时。硫唑嘌呤可用于诱导三型自身免疫性多腺体综合征缓解，尤其是伴有白癜风和自身免疫性甲状腺炎时。
Zotero 插件